Supply constraints push EpiPen rival maker Amneal to restructure, shares fall
Amneal Pharmaceuticals, which sells a generic epinephrine auto-injector similar to Mylan’s flagship Epipen, has initiated a sweeping restructuring of its business driven primarily by the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
